-transparent.png){kind=logo}
Clozapine, a new antipsychotic drug without extrapyramidal side effects and with strong sedating potency, can produce acute symptoms of central anticholinergic toxicity. The authors report that physostigmine, a reversible anticholinesterase agent, which can pass the blood-brain barrier, was effective in reversing the clozapine-induced brain syndrome in two patients. Physostigmine also reduced one patient's tachycardia.
Related Publications
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
May 1977,
Anesthesiology,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
January 1975,
Anesthesia and analgesia,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
November 1974,
The American journal of psychiatry,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
February 1983,
Journal of clinical psychopharmacology,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
February 1980,
The Nebraska medical journal,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
February 1971,
The American journal of psychiatry,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
June 1973,
American journal of obstetrics and gynecology,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
May 1976,
American family physician,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
September 1979,
JAMA,
P Schuster, and
E Gabriel, and
B Küfferle, and
G Strobl, and
M Karobath
January 1976,
Anesthesia and analgesia,
